ADIPOQ and Insulin resistance: Several studies have demonstrated an inverse association between circulating adiponectin levels in vivo and the risk of malignances associated with obesity and insulin resistance videlicet, endometrial cancer [165], postmenopausal breast cancer [166], leukemia [167] and colon cancer [168].